ChromoLogic

ChromoLogic is a California-based innovation center and venture studio that develops and commercializes disruptive technologies across the medical, aerospace, and security sectors. The company operates through a multi-disciplinary approach, leveraging expertise in areas such as optics, microfluidics, biomarker discovery, and neuromorphic computing to create advanced diagnostic, sensing, and supply chain solutions. By partnering with universities and utilizing federally funded research programs, ChromoLogic incubates breakthrough technologies, evaluating their commercial potential to form spin-out ventures. Its technical capabilities include the development of point-of-care healthcare platforms, drug delivery systems, and innovative asset authentication tools, often employing biology-inspired designs to address complex scientific and engineering challenges.

These solutions are designed to address critical needs in high-risk environments, including those faced by military personnel, first responders, and industries requiring high-precision traceability and security. For customers and partners, ChromoLogic provides a pathway to modernize capabilities in fields ranging from wound care and infectious disease diagnostics to industrial asset protection and autonomous sensor systems. The organization has demonstrated its impact through projects supported by public and private sector entities, including NASA and the U.S. Department of Defense. By fostering a collaborative environment that bridges basic research and commercial application, the company helps organizations enhance operational security, supply chain integrity, and health outcomes. Notably, its vTag technology for supply chain assurance has been successfully transitioned to the spin-off company Covisus Inc.